These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32087088)
1. Gene dose matters: Considerations for the use of inducible CD4-CreER Zeiträg J; Alterauge D; Dahlström F; Baumjohann D Eur J Immunol; 2020 Apr; 50(4):603-605. PubMed ID: 32087088 [TBL] [Abstract][Full Text] [Related]
2. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810 [TBL] [Abstract][Full Text] [Related]
3. Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines. Hu NY; Chen YT; Wang Q; Jie W; Liu YS; You QL; Li ZL; Li XW; Reibel S; Pfrieger FW; Yang JM; Gao TM Neurosci Bull; 2020 May; 36(5):530-544. PubMed ID: 31828740 [TBL] [Abstract][Full Text] [Related]
4. High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. Forni PE; Scuoppo C; Imayoshi I; Taulli R; Dastrù W; Sala V; Betz UA; Muzzi P; Martinuzzi D; Vercelli AE; Kageyama R; Ponzetto C J Neurosci; 2006 Sep; 26(37):9593-602. PubMed ID: 16971543 [TBL] [Abstract][Full Text] [Related]
6. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER Xu J; Yao G; Ru Y; Xie S Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines. Stone JS; Wisner SR; Bucks SA; Mellado Lagarde MM; Cox BC J Assoc Res Otolaryngol; 2018 Aug; 19(4):381-399. PubMed ID: 29869046 [TBL] [Abstract][Full Text] [Related]
8. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity. Undeutsch H; Löf C; Offermanns S; Kero J Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757 [TBL] [Abstract][Full Text] [Related]
9. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice. Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167 [TBL] [Abstract][Full Text] [Related]
10. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo. Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988 [TBL] [Abstract][Full Text] [Related]
11. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373 [TBL] [Abstract][Full Text] [Related]
12. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877 [TBL] [Abstract][Full Text] [Related]
13. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector. Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440 [TBL] [Abstract][Full Text] [Related]